Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
04/15/2010 | WO2010018837A3 Protein cross-linking inhibitor |
04/15/2010 | WO2010018836A3 Polyglutamine aggregation inhibitor |
04/15/2010 | US20100093873 Methods of improving therapy of perfluorocarbons (PFC) |
04/15/2010 | US20100093871 Agent for prevention or treatment of iron overload disorders |
04/15/2010 | US20100093870 Herbal medicaments for the treatment of neurocerebrovascular disorders |
04/15/2010 | US20100093786 Pharmaceutical composition containing low-substituted hydroxypropyl cellulose |
04/15/2010 | US20100093785 Diamine derivatives |
04/15/2010 | US20100093772 Quinazoline derivatives and their use in the treatment of thrombocythemia |
04/15/2010 | US20100093768 Agents for Reversing Epigenetic Silencing of Genes |
04/15/2010 | US20100093717 Triazole compounds that modulate hsp90 activity |
04/15/2010 | US20100093690 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
04/15/2010 | US20100093687 Method Of Treating Disorder Related To High Cholesterol Concentration |
04/15/2010 | US20100093634 Methods for regulating urinary potassium |
04/15/2010 | US20100093632 Enamel matrix protein composition for treatment of systemic inflammatory response |
04/15/2010 | US20100093608 Modified animal erythropoietin polypeptides and their uses |
04/15/2010 | US20100093003 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
04/15/2010 | US20100092573 Hemostatic bio-material composition and method |
04/15/2010 | US20100092436 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
04/15/2010 | US20100092434 Thrombopoietic activity of tyrosyl-trna synthetase polypeptides |
04/15/2010 | US20100089840 Removal of Adenine During A Pathogen Reduction Process in Whole Blood or Red Blood Cells by Dilution |
04/15/2010 | CA2737401A1 Iron source product in the form of capsules and process for their preparation |
04/15/2010 | CA2736930A1 1-phenylpyrrole compounds |
04/14/2010 | EP2174956A1 Compositions for anti-fibrinolitic treatment |
04/14/2010 | EP2174657A1 Iron source product in the form of capsules and process for their prepartion |
04/14/2010 | EP2174656A1 Microparticles of alginate modified with rgd as a release system for medicines |
04/14/2010 | EP2173744A1 Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation |
04/14/2010 | EP2173351A2 Compounds and methods for treatment of sickle cell disease or complications associated therewith |
04/14/2010 | EP1858890B1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments |
04/14/2010 | CN1973864B Medicine composition for treating hematuria and nephropyelitis and its preparation |
04/14/2010 | CN1935230B Chinese medicine injection preparation and its preparing method |
04/14/2010 | CN1899357B Method for producing persimmon frost medicine |
04/14/2010 | CN1853674B Quality controlling method of Xingdan injection |
04/14/2010 | CN101693888A Yellow mealworm plasmin and preparation method and applications thereof |
04/14/2010 | CN101693718A Ester derivative containing thienopyridine and preparation method and application thereof |
04/14/2010 | CN101693105A Application of IL-4-like recombinant protein of fishes |
04/14/2010 | CN101693051A Preparation method and composition of clerodendranthus spicatus extract |
04/14/2010 | CN101693024A Radionuclide-labelled biodegradable bioabsorbable biopolymer nano fibrous membrane, preparation process and application thereof |
04/14/2010 | CN101693015A Coenzyme A medicament freeze-drying preparation and process for preparing same |
04/14/2010 | CN101693014A Process for preparing coenzyme A medicament freeze drying preparation |
04/14/2010 | CN101444491B Ozagrel sodium microballoon lyophilized preparation and preparation method thereof |
04/13/2010 | US7696331 parenterally administering a dose of samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and carboplatin or taxoids; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
04/13/2010 | US7696246 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
04/13/2010 | US7696193 Such as 6-(3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yloxy)-N-methyl-nicotinamide; for treatment of neurological and psychiatric disorders |
04/13/2010 | US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder |
04/13/2010 | CA2436220C New mandelic acid derivatives and their use as thrombin inhibitors |
04/13/2010 | CA2432150C Glycosaminoglycans derived from k5 polysaccharide having high antithrombin activity and process for their preparation |
04/13/2010 | CA2430363C Compounds and their uses |
04/13/2010 | CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
04/13/2010 | CA2213721C Method for stabilizing platelets |
04/13/2010 | CA2203528C Methods and kits using macrophage stimulating protein |
04/08/2010 | WO2010038714A1 Lactic acid bacterium having high oxalic acid decomposition ability |
04/08/2010 | WO2010038689A1 Pharmaceutical composition for oral administration |
04/08/2010 | WO2010037179A1 Anionic conjugates of glycosylated bacterial metabolite |
04/08/2010 | WO2010017122A3 Methods of treating thalassemia |
04/08/2010 | WO2010005692A3 Insecticidal cyclic carbonyl amidines |
04/08/2010 | WO2009115614A3 Von willebrand factor specific binders and methods of use therefor |
04/08/2010 | US20100087651 New mandelic acid derivatives and their use as thrombin inhibitors |
04/08/2010 | US20100087488 Physiologically Acceptable Salts of 3-[(2--1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
04/08/2010 | US20100087393 Methods and compositions of inhibiting complement and cellular activation with dextran sulfate |
04/08/2010 | US20100087361 Method to enhance hemodynamic stability using oxygen carrying compositions |
04/08/2010 | US20100086567 Botulinum toxin therapy for prevention of anastamotic thrombosis in free tissue transfer |
04/08/2010 | US20100086542 Potentiation of erythropoietin (epo) action by membrane steroid receptor agonists |
04/08/2010 | CA2739345A1 Lactic acid bacterium having high oxalic acid decomposition ability |
04/08/2010 | CA2738912A1 Pharmaceutical composition for oral administration |
04/07/2010 | EP2172544A1 Novel adamts-13 mutant |
04/07/2010 | EP2172468A1 Benzimidazolone compounds |
04/07/2010 | EP2172458A1 Pyrazolone derivative |
04/07/2010 | EP2170877A1 Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation |
04/07/2010 | EP2170831A1 Benzazepine derivatives useful as vasopressin antagonists |
04/07/2010 | EP1322752B1 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
04/07/2010 | CN101691324A Method for preparing 3-(2-hydroxy-4-methoxyphenyl)-1-(4-methoxy)-1-propanol |
04/07/2010 | CN101690764A Traditional Chinese medicine for treating cardiac, cerebral and vascular diseases and preparation method thereof |
04/07/2010 | CN101690759A Health product for improving nutritional anemia and preparation method thereof |
04/07/2010 | CN101690754A Medicine for curing cerebral thrombosis sequela |
04/07/2010 | CN101690735A Complex microorganism health-protection agent and preparation method thereof |
04/07/2010 | CN101690733A Leech enzymatic acetone powder enteric preparation and preparation method and application thereof |
04/07/2010 | CN101690719A Bisulfate clopidogrel solid preparation, particles and preparation method thereof |
04/07/2010 | CN101690564A Natto product capable of dissolving thrombus |
04/07/2010 | CN101690548A Method for producing feed additive for preventing and curing pig anemia |
04/07/2010 | CN101161265B Medicament taken orally for treating aplastic anemia |
04/06/2010 | US7691995 Engineered RNA precursors encoded in plasmids and/or other vectors; simple, low cost technique utilizing DNA molecule production; host cells, transgenes |
04/06/2010 | US7691967 Smart pro-drugs of serine protease inhibitors |
04/06/2010 | US7691897 Therapeutic agent |
04/06/2010 | US7691846 blood coagulation factor (trypsin-like serine protease enzymes) inhibitor; 1-(3-amino-1,2-benzisoxazol-5-yl)-5-{[5-(2-oxo-1-piperidinyl)-2,3-dihydro-1H-indol-1-yl]carbonyl}-1H-pyrazole-3-carboxamide; anticoagulant; cardiovascular thromboembolic disorder transient ischemic attack, stroke, atherosclerosis |
04/06/2010 | US7691844 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; inner ear disorders, hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure |
04/06/2010 | US7691425 Method for manufacturing α-glycosylisoquercitrin, intermediate product and by-product thereof |
04/06/2010 | US7691416 kit for administering a pharmaceutical composition that includes carbon monoxide to the patient in angioplasty procedures and for treating a donor, organ, and/or recipient with carbon monoxide during a transplantation procedure |
04/06/2010 | US7691387 Cinnamomi and poria composition, method to prepare same and uses thereof |
04/06/2010 | CA2455510C A hemostatic composition |
04/06/2010 | CA2455181C Benzimidazo[4,5-f]isoquinolinone derivatives |
04/06/2010 | CA2416220C Preparation of phosphatase inhibitors |
04/06/2010 | CA2406807C Methods and compositions for the prevention and treatment of anemia |
04/06/2010 | CA2397636C Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
04/06/2010 | CA2351709C Novel triazolo(4,5-d)pyrimidine compounds |
04/01/2010 | WO2010036964A2 Modified animal erythropoietin polypeptides and their uses |
04/01/2010 | WO2010035806A1 Solid pharmaceutical composition |
04/01/2010 | WO2010035769A1 Improved antibody molecule |
04/01/2010 | WO2010035750A1 Method for producing lipid |
04/01/2010 | WO2010035749A1 Method for concentrating lipid |
04/01/2010 | WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient |